Your Call Is Confidential
Call Us Today (202) 973-0900


Category Archives: Blog

PharMerica Long-Term Pharmacy to Pay U.S. Government $31.5 Million for Allegedly Violating Controlled Substance Ac t and False Claims Act

On May 15, 2015, the Department of Justice (DOJ) announced that PharMercia Corporation, a comprehensive long-term provider of pharmacy services, operating across the country, agreed to pay the U.S. Government $31.5 million for allegedly violating the Controlled Substance Act (CSA) by knowingly dispensing Schedule II controlled drugs to residences of long-term care facilities without a […]

Continue Reading

Federal Court Allows False Claims Act Allegations To Proceed Against Doctor Billing Medicare For Unreasonably “High Volume” Of Patients

Medicare fraud is pervasive, and often gives rise to claims under the False Claims Act (FCA), including so-called “qui tam” lawsuits brought by whistleblowers.  The ways in which doctors, practice groups, and other healthcare service providers commit fraud is far-ranging, and the manner in which whistleblowers and the government can prove fraud is constantly evolving.  […]

Continue Reading

Software Company And Its Owner To Pay $9 Million to Settle False Claims Act Case Alleging Use Of Noncompliant Workers On Government Contracts

On May 7, 2015, the Department of Justice (DOJ) announced that Global Computer Enterprises, Inc. (GCE) located in Reston, Virginia, and GCE’s sole owner and president, Raed Muslimani, agreed to pay the U.S. Government $9 million to resolve allegations that GCE violated the False Claims Act (FCA) when it hired noncompliant workers to perform contractual […]

Continue Reading

DaVita Agree to $495 Million Settlement in Alleged Medicare Fraud Lawsuit Filed by Qui Tam Whistleblowers

On Monday, May 4, 2015, DaVita Kidney Care, a division of DaVita Healthcare Partners, Inc. (DaVita), and one of the leading dialysis services providers in the United States, agreed to pay the U.S. Government $450 for allegedly violating the False Claims Act (FCA) when it continuously discarded good medicine and then billed Medicare and Medicaid […]

Continue Reading

Senate Approves the Motor Vehicle Safety Whistleblower Act

The United States Senate recently approved new legislation extending whistleblower rights and protections to the field of automotive safety.  In light of public outrage sparked by the General Motors defective ignition switches and Takada exploding airbags scandals—and the fact that the Department of Transportation was apparently caught flat-footed when the scandals broke—the Senate enacted legislation […]

Continue Reading

Georgia Hospital to Pay $20 Million for Allegedly Overbilling the Government for In-Patient vs. Out-Patient Hospital Care

On Monday, April 27, 2015, the Department of Justice (DOJ) announced that The Medical Center of Central Georgia (MCCG), the second largest hospital in Macon, Georgia, agreed to a $20 million settlement to resolve allegations that it violated the False Claims Act (FCA) by overbilling Medicare for unnecessary inpatient care.  According to the lawsuit filed […]

Continue Reading

County-Owned Medical Center in Texas Agrees to Pay the Government $21.75 million To Resolve Qui Tam Case Alleging Illegal Kickbacks to Physicians

On April 21, 2015, the Department of Justice (DOJ) announced that Citizens Medical Center (CMC) a county-own hospital located in Victoria, Texas agreed to pay the Government a settlement of $21.75 million to resolve claims that it violated the Stark law and the False Claims Act (FCA) by allegedly paying kickbacks to doctors for patient […]

Continue Reading

Government to Receive $48.5 Million Settlement from Two Cardiovascular Testing Diseases Laboratories for Allegedly Violating the Anti-Kickback Statue

On April 9, 2015, the Department of Justice (DOJ) announced that two cardiovascular disease testing laboratories based in Virginia and California agreed to pay the government $48.5 million to resolve allegations that it violated the Anti-Kickback Statue and the False Claims Act (FCA) by allegedly paying inducements to physicians for referring patients to its laboratories […]

Continue Reading

SEC Warns Companies Not To Try To Silence Potential Whistleblowers

The Securities and Exchange Commission (“SEC”) brought a ground-breaking enforcement action against one of the country’s largest government contractors, Kellogg Brown & Root (KBR), stemming from KBR’s use of a confidentiality agreement arguably aimed at intimidating employees and former employees from blowing the whistle on fraud.  KBR recently settled the case, agreeing to pay a […]

Continue Reading